Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Acta Oncol. 2018 Oct 23;58(2):154–161. doi: 10.1080/0284186X.2018.1503419

Figure 2:

Figure 2:

Immunohistochemical analysis of nuclear and cytoplasmic survivin expression. (A) IHC ×10 high cytoplasmic staining intensity, magnified to (B) IHC ×40, 60% high intensity, 40% low intensity. (C) IHC ×10 low/medium nuclear staining intensity, magnified to (D) IHC ×40, 5% medium intensity, 3% low intensity.